KCHC-AR-2023 Final Signed - Flipbook - Page 60
Notes to the financial statements
2 Analysis of funds and movements on funds
2.1. Movements in funds between the beginning and end of the financial year
of £4.2m (2021/22 surplus of £1.8m) after investment
losses of £2.3m (2021/22 £1.4m gain) resulting from the
decrease (2021/22 increase) in investment values.
During 2022/23, the value of the total funds held by
the Charity decreased by £4.2m (2021/22: increased by
£1.8m). Expenditure in the year was £1.8m higher than
income (2021/22: £0.4m lower) resulting in a deficit
At 1
April
2022
£’000
Expenditure
£’000
Gains/
(Losses)
£’000
Transfers
£’000
At 31
March
2023
£’000
Income
£’000
-
100
-
-
-
100
Cancer treatment and
research
248
-
-
-
(248)
-
Paediatric liver laboratories
290
55
-
-
-
345
David Hughes Special Trust
2,474
-
-
-
(165)
2,309
267
35
(113)
-
-
189
Renal Legacy - Spratt
-
571
-
-
-
571
Paediatric palliative care
CNS True Colours
-
60
(120)
-
-
(60)
Robot Assisted Surgical
System
-
-
(1,000)
-
1,000
-
197
81
(12)
-
45
311
3,476
802
(1,245)
-
632
3,665
9,746
990
(988)
-
(777)
8,971
-
-
-
-
-
-
Fund for strategic grants
6,903
-
-
-
(3,403)
3,500
Development of capital
projects
1,000
-
-
-
-
1,000
Office fixtures & fittings
33
-
-
-
-
33
17,682
990
(988)
-
(4,180)
13,504
6,007
1,813
(3,326)
(2,320)
3,548
5,722
Total unrestricted funds
23,689
2,803
(4,314)
(2,320)
(632)
19,226
Total funds
27,165
3,705
(5,559)
(2,320)
-
22,991
Permanent endowment
funds
Restricted funds
Transforming Liver Care
(TLC) Appeal
Other funds less than £100k
Total restricted funds
Unrestricted funds
Designated
Clinical funds
Social investment
Total designated funds
General funds
60
S U P P O R T K I N G S .O R G .U K
